Atea Pharmaceuticals, Inc. (AVIR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Atea Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.84x | -1.68x | -1.87x | -3.45x | 6.11x | -314.63x |
| P/B Ratio | 1.06x | 0.64x | 0.46x | 0.63x | 1.04x | 6.29x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 2.11x | 70.82x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 52.4% | 21.8% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 39.4% | -22.7% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 34.5% | -22.5% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 39.4% | -22.6% |
| Liquidity | ||||||
| Current Ratio | 7.82x | 24.85x | 18.24x | 35.77x | 13.58x | 2.73x |
| Quick Ratio | 7.82x | 24.85x | 18.24x | 35.77x | 13.58x | 2.73x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..